SHALENI WATTS: Open Payments
NPI 1659978591 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 16 payments from 8 companies in 2025. Trend: 2023 $449 · 2024 $306 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $138 |
| Vanda Pharmaceuticals Inc. | 2 | $133 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Corium, LLC | 1 | $5 |
Products named: FANAPT, MAVYRET, VRAYLAR, INGREZZA, JARDIANCE, Ozempic, Auvelity, Jornay PM.
Industry payments across IN — which companies pay providers there.
